X0206 3 2013-07-24 0 0001383701 Conatus Pharmaceuticals Inc CNAT 0001024004 HALE DAVID F C/O CONATUS PHARMACEUTICALS INC. 4365 EXECUTIVE DRIVE, SUITE 200 SAN DIEGO CA 92121 1 0 0 0 Common Stock 121211 I See footnote Stock Option (Right to Buy) 0.99 2021-02-16 Common Stock 12121 D Stock Option (Right to Buy) 2.31 2023-03-06 Common Stock 12121 D Series A Preferred Stock 0.00 Common Stock 19679 I See footnote Warrant to Purchase Shares of Series B Preferred Stock 0.90 2018-05-30 Series B Preferred Stock 3480 I See footnote Represents 109,090 shares held by Hale BioPharma Ventures, LLC and 12,121 shares held by Hale Trading Company, LP. Mr. Hale holds sole voting and investment power with respect to the shares held by these entities. Immediately exercisable. Immediately convertible/exercisable. The shares are not subject to expiration. Held by Hale BioPharma Ventures, LLC of which Mr. Hale serves as CEO. Mr. Hale holds sole voting and investment power with respect to the securities held by that entity. /s/ Charles J. Cashion, Attorney-in-Fact for David F. Hale 2013-07-24